Working to Eradicate Gynecologic Cancers

Leslie M. Randall, MD

Assistant Professor of Clinical Obstetrics & Gynecology
University of California at Irvine Medical Center
101 The City Dr. South, Bldg 56
Rm 262
Orange, CA
USA 92868


Biographical Sketch:
Randall LM, et al. Markers of angiogenesis in high-risk, early-stage cervical cancer: A GOG study. Gynecol Oncol. 2009 Mar; 112(3):583-9. Randall LM, et al. Predictive value of serum CA-125 levels in patients with persistent or recurrent epithelial ovarian cancer or peritoneal cancer treated with bevacizumab on a GOG phase II trial. Gynecol Oncol 2011"

Papers:
Crisis aversion and disaster management for anti-angiogenic therapy Transition into the next phase